Roivant Sciences Ownership | Who Owns Roivant Sciences?
Roivant Sciences Ownership Summary
Roivant Sciences is owned by 72.71% institutional investors, 26.39% insiders, and 0.90% retail investors. Sb investment advisers (uk) is the largest institutional shareholder, holding 8.48% of ROIV shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.69% of its assets in Roivant Sciences shares.
ROIV Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Roivant Sciences | 72.71% | 26.39% | 0.90% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Sb investment advisers (uk) | 59.95M | 8.48% | $675.67M |
Fmr | 49.30M | 6.70% | $583.24M |
Vanguard group | 44.09M | 5.99% | $521.55M |
Blackrock funding, inc. /de | 40.32M | 5.70% | $454.36M |
Viking global investors lp | 34.24M | 4.84% | $385.86M |
Blackrock | 35.37M | 4.41% | $373.86M |
Qvt financial lp | 29.38M | 4.15% | $331.13M |
Morgan stanley | 29.33M | 3.65% | $310.02M |
Rubric capital management lp | 17.77M | 2.46% | $179.27M |
State street | 18.44M | 2.30% | $194.94M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Patient square capital lp | 12.48M | 50.71% | $140.65M |
Atalaya capital management lp | 1.71M | 40.31% | $18.13M |
Qvt financial lp | 29.38M | 29.50% | $331.13M |
Anchorage capital group | 4.83M | 21.05% | $54.46M |
Whitefort capital management, lp | 3.88M | 12.84% | $43.75M |
Cutter capital management, lp | 1.30M | 5.71% | $13.12M |
Sb investment advisers (uk) | 59.95M | 5.36% | $675.67M |
Prosight management, lp | 1.81M | 4.97% | $20.38M |
Adar1 capital management | 1.94M | 3.35% | $21.87M |
Ghost tree capital | 1.00M | 3.31% | $10.57M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ubs group | 5.29M | 0.01% | 4.78M |
Norges bank | 4.43M | 0.01% | 4.43M |
Perceptive advisors | 3.33M | 1.39% | 3.33M |
Invesco | 9.52M | 0.02% | 3.16M |
Orbimed advisors | 2.78M | 0.78% | 2.78M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Qvt financial lp | 29.38M | 29.50% | -36.41M |
Viking global investors lp | 34.24M | 1.12% | -11.78M |
Morgan stanley | 29.33M | 0.02% | -6.31M |
Avoro capital advisors | - | - | -4.65M |
Toms capital investment management lp | - | - | -4.09M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 4.43M | 0.01% | 4.43M | $52.44M |
Perceptive advisors | 3.33M | 1.39% | 3.33M | $37.55M |
Orbimed advisors | 2.78M | 0.78% | 2.78M | $31.32M |
Cutter capital management, lp | 1.30M | 5.71% | 1.30M | $13.12M |
Balyasny asset management | 969.98K | 0.02% | 969.98K | $10.93M |
Sold Out
Holder | Change |
---|---|
Tfc financial management | -2.00 |
Mather group, llc. | -13.00 |
American capital advisory | -19.00 |
Cornerstone planning group | -27.00 |
Riverview trust | -45.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 351 | 8.67% | 514,292,667 | -7.04% | 72 | 1.24% | 180 | 19.21% | 107 | 0.94% |
Mar 31, 2025 | 15 | -95.41% | 102,194,746 | -81.83% | 14 | 0.23% | 6 | -96.18% | 3 | -97.12% |
Dec 31, 2024 | 293 | -4.87% | 455,984,070 | -19.26% | 61 | 1.05% | 142 | -20.22% | 95 | 35.71% |
Sep 30, 2024 | 306 | 0.66% | 564,022,060 | 3.35% | 76 | 1.39% | 177 | 4.12% | 69 | -14.81% |
Jun 30, 2024 | 303 | 14.34% | 545,755,248 | 3.61% | 67 | 1.57% | 169 | 6.29% | 81 | 24.62% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 25.17M | 3.69% | 748.06K |
Fidelity Growth Compy Commingled Pl O | 21.15M | 2.86% | 439.20K |
Fidelity Growth Company Fund | 18.62M | 2.73% | 1.10M |
iShares Core S&P Mid-Cap ETF | 13.72M | 2.01% | -24.64K |
Vanguard US Total Market Shares ETF | 14.26M | 2.00% | 14.26M |
Vanguard Total Stock Mkt Idx Inv | 13.12M | 1.92% | -274.00K |
Vanguard Small Cap Index | 9.90M | 1.45% | -71.12K |
SPDR® S&P Biotech ETF | 7.17M | 1.05% | 176.82K |
Invesco S&P MidCap Quality ETF | 6.02M | 0.89% | - |
Vanguard Small Cap Growth Index Inv | 5.57M | 0.82% | -22.41K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 04, 2025 | Ramaswamy Vivek | - | Sell | $2.52M |
Sep 03, 2025 | Ramaswamy Vivek | - | Sell | $14.94M |
Sep 05, 2025 | Ramaswamy Vivek | - | Sell | $5.00M |
Aug 20, 2025 | Venker Eric | President & Immunovant CEO | Sell | $1.17M |
Jul 21, 2025 | Venker Eric | President & Immunovant CEO | Sell | $1.15M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 5 |
2025 Q2 | - | 11 |
2025 Q1 | - | 7 |
2024 Q4 | - | 8 |
2024 Q3 | - | 12 |
ROIV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools